09:13 AM EST, 11/22/2024 (MT Newswires) -- Health care stocks were advancing premarket Friday, with The Health Care Select Sector SPDR Fund ( XLV ) up 0.3% and the iShares Biotechnology ETF (IBB) 0.4% higher.

Halozyme Therapeutics ( HALO ) shares were up over 11% after the company said it has withdrawn its proposal to acquire Evotec (EVO) for 11 euro ($11.47) per share in cash. Evotec shares were down past 20% pre-bell.

Eyenovia ( EYEN ) shares were over 9% higher after the company said Avenue Capital Management has agreed to support a potential restructuring of Eyenovia's ( EYEN ) loan and security agreement, and defer principal and interest payments on its outstanding debt until the end of February 2025.

Amneal Pharmaceuticals ( AMRX ) shares advanced by over 4% after the company said US regulators have approved its exenatide formulation as an adjunct treatment to help control glucose levels in the bloodstream of adults with type 2 diabetes mellitus.